Related Experiment Videos
Microarray analysis of gene expression in chondrosarcoma cells treated with bee venom
Chang Shik Yin1, Hee Jae Lee, Seung-Jae Hong
1Department of Acupuncture, Kyung Hee University Hospital, 1 Hoegi-dong, Dongdaemun-gu, Seoul, 130-702, South Korea.
Summary
Bee venom (BV) treatment downregulates specific genes in human chondrocytes, potentially reversing inflammation associated with arthritis. Microarray analysis revealed BV
Area of Science:
- * Molecular Biology
- * Immunology
- * Pharmacology
Background:
- * Bee venom (BV) is utilized in Korean medicine for inflammatory conditions like arthritis.
- * Chondrocyte dysfunction is central to the pathogenesis of arthropathies, leading to cartilage destruction.
- * Understanding gene expression changes is crucial for elucidating BV's therapeutic mechanisms.
Purpose of the Study:
- * To investigate the global gene expression profiles of human chondrocytes treated with bee venom (BV).
- * To analyze the effects of BV, lipopolysaccharide (LPS), and their co-stimulation on gene expression.
- * To identify specific genes modulated by BV that may relate to its anti-arthritic properties.
Main Methods:
- * Microarray analysis was performed on HTB-94 human chondrosarcoma cells.
- * Cells were treated with BV, LPS, or a combination of both.
- * Gene expression changes were analyzed with a cut-off level of 4-fold change.
Main Results:
- * BV treatment downregulated 35 genes.
- * LPS treatment upregulated 16 genes and downregulated 7 genes.
- * Co-stimulation with BV and LPS downregulated 32 genes.
- * BV reversed LPS-induced upregulation of genes including IL-6 receptor, MMP-15, and TIMP-1.
Conclusions:
- * Bee venom influences global gene expression in human chondrocytes.
- * BV demonstrates potential to counteract inflammatory gene upregulation induced by LPS.
- * Microarray analysis is a valuable tool for understanding the pharmacological actions of BV in arthritis treatment.